NCT03034850
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +16 more
- Locations
-
Not specified
Clinical trial condition
Pseudomyxoma Peritonei
Explore clinical trials studying Pseudomyxoma Peritonei. Study availability and eligibility vary by location and protocol.
26 public trials
11 recruiting studies
Pseudomyxoma Peritonei trial results
NCT01764789
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +79 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT01652794
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adnexal Diseases, +51 more
- Locations
-
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00005860
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +71 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
NCT02387203
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Neoplasms, +15 more
- Locations
-
- Mercy Medical Center Baltimore, Maryland, United States